Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Birth Defects Res B Dev Reprod Toxicol. 2012 Mar 22;95(3):231–237. doi: 10.1002/bdrb.21011

Fig. 3.

Fig. 3

Incidence of tail and body malformations in mouse fetuses following maternal exposure to cyclophosphamide (CP) during gestation, with or without exposure to green tea extract (GTE). aSignificantly different from CP 20 (P≤0.01); bSignificantly different from CP 20(P≤0.05).